Trials / Completed
CompletedNCT02061839
Prevention of Melasma Relapse During Summertime
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Centre de Pharmacologie Clinique Applique a la Dermatologie · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Main objective is to show that a photoprotective sunscreen having a protection against the visible light is more effective than a sunscreen having the same UVA AND UVB protection but with a low (weak) protection against the visible, to prevent the relapses of the melasma during the summertime.
Detailed description
40 melasma affected women will be included and randomized in two parallel groups (one group protected by a UVA+UVB+visible extended sunscreen and one group group protected by a UVA+UVB sunscreen). There will be 3 visits: Baseline, T2.5months and T5months (final visit). Products application frequency: twice daily(morning and afternoon) and additional applications every 2 hours in case of solar exposure. Main evaluation criterion: the MASI score assessed from standardized photographs (system VISIA, Canfield Scientific, USA) at Baseline, middle and end of study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sunscream with visible light protection | |
| OTHER | Sunscream |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2013-08-01
- Completion
- 2013-10-01
- First posted
- 2014-02-13
- Last updated
- 2014-02-13
Source: ClinicalTrials.gov record NCT02061839. Inclusion in this directory is not an endorsement.